Susquehanna International Group, LLP Lineage Cell Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$1.16 - $1.53 $16,820 - $22,185	14,500 New	14,500 $17,000
Q3 2022 Nov 14, 2022	SELL	$1.13 - $1.77 $90,964 - $142,485	-80,500 Reduced 49.78%	81,200 $92,000
Q2 2022 Aug 15, 2022	BUY	$1.12 - $1.61 $12,768 - $18,354	11,400 Added 7.58%	161,700 $255,000
Q1 2022 May 16, 2022	SELL	$1.21 - $2.48 $246,356 - $504,928	-203,600 Reduced 57.53%	150,300 $231,000
Q4 2021 Feb 14, 2022	SELL	$1.84 - $2.68 $106,168 - $154,636	-57,700 Reduced 14.02%	353,900 $867,000
Q3 2021 Nov 15, 2021	BUY	$2.26 - $2.86 $628,279 - $795,080	278,000 Added 208.08%	411,600 $1.04 Million
Q2 2021 Aug 11, 2021	BUY	$2.17 - $3.0 $256,494 - $354,600	118,200 Added 767.53%	133,600 $381,000
Q1 2021 May 17, 2021	SELL	$1.77 - $3.1 $759,153 - $1.33 Million	-428,900 Reduced 96.53%	15,400 $36,000
Q4 2020 Feb 16, 2021	BUY	$0.95 - $1.83 $377,625 - $727,425	397,500 Added 849.36%	444,300 $782,000
Q3 2020 Nov 16, 2020	BUY	$0.75 - $1.09 $4,800 - $6,976	6,400 Added 15.84%	46,800 $44,000
Q2 2020 Aug 14, 2020	SELL	$0.71 - $1.18 $18,460 - $30,680	-26,000 Reduced 39.16%	40,400 $35,000
Q1 2020 May 15, 2020	BUY	$0.6 - $1.58 $28,560 - $75,208	47,600 Added 253.19%	66,400 $55,000
Q3 2019 Nov 14, 2019	BUY	$0.85 - $1.24 $15,980 - $23,312	18,800 New	18,800 $18,000

122

94.3M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $146M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.